订阅小程序
旧版功能

Toxicity and Efficacy Outcomes of Teclistamab in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) above the Age of 70 Years: A Multicenter Study

BLOOD(2023)

引用 5|浏览14
关键词
Tumor Regression
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要